HOTTIP and hepatocellular carcinoma: reported that solamargine inhibited the expression of lncRNA HOTTIP and TUG1, increased miR-4726-5p expression and inhibited MUC1 expression in HCC cells, leading to inhibition of cell growth and promotion of sorafenib efficacy (50).